Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Follow @Orphanet on social media
Orphanet is present on Linkedin and Facebook. Follow us to keep up to date with Orphanet's latest activities and developments.
For information on a rare disease
Write the name of the disease (or only part of the name) in the box provided on the front page, then click on 'search'.
We do not answer questions relating to information on diseases, as all available information at our disposal is freely accessible on the web site.
If you cannot find the information you are searching for, please consult the alphabetical list of diseases, or try another approximate spelling. If you are still unable to find the information you require, please send us a message by email: contact.orphanet@inserm.fr
For a research collaboration or a study
If you would like to obtain a substantial amount of information from the database for research work, a report or personal use: www.orphadata.com.
For a personal query
Orphanet cannot answer personal queries. You should contact a dedicated service.
https://www.radiorg.be/nl/
www.rqmo.org
//helpline.nih.go.kr/cdchelp/index.gst
www.maladiesraresinfo.org
www.hse.ie/eng/services/list/5/rarediseases/whatwedo.html
NKSD - Nasjonal kompetansetjeneste for sjeldne diagnoser)
www.sjeldne-diagnoser.no/
//www.info-maladies-rares.ch/
//www.kispi.uzh.ch/helpline-selten
https://www.ukbb.ch/de/Rare-Diseases.php
www.rarediseases.info.nih.gov/GARD/Default.aspx
To register an activity
Please complete the short questionnaire: Register / Update your activity
For other purposes
- For technical requests regarding connection: informatique.orphanet@inserm.fr
- Contact the information team to report content to modify: contact.orphanet@inserm.fr
- Contact the communications team: media.orphanet@inserm.fr
- Contact the national Orphanet teams:
Contact the coordinating team
- Orphanet / INSERM US14
- Rare Disease Platform
- 96, rue Didot
- 75014 Paris, France
Phone: +33 (0)1.56.53.81.37
To locate our office in Paris, please consult the map.